The Focused Ultrasound Field is Growing
To help accelerate the development of focused ultrasound, part of the Foundation’s role is to assess where the field has been, where it is now, and where it is going.
Every year, we survey the community to monitor the pulse of where research is being conducted, what progress is being made across a range of diseases, which sites are providing treatments, and the current regulatory status of different manufacturers’ systems. This work is summarized in our State of the Field Report. This report helps researchers and industry identify collaborators, assists patients in locating treatment sites, and illuminates the potential of the technology for reporters, investors, and others.
This Focus Feature highlights the key statistics and trends in the 2015 Report, which summarizes data gathered in 2014. Focused ultrasound technology is steadily evolving from being used by a select group of innovators at academic centers to making strides in patient care by influential early adopters.
There are currently 28 focused ultrasound manufacturers, 225 research sites, and 391 commercial treatment centers worldwide. More than 8,000 patients were treated commercially or in clinical trials in 2014. To date, nearly 90,000 patients have undergone focused ultrasound treatment. Approved to treat 19 medical conditions in regions around the world, focused ultrasound has been most widely used to treat prostate cancer, uterine fibroids and liver cancer.
Treatments by Indication
Read this report to find out more about: